Episodes of exercise-induced dark urine and myalgia in LGMD 2I

Acta Neurologica Scandinavica

Volumn 125, Issue 4, 2012, Pages 285-287

  Lindberg, C ^a   Sixt, C ^a   Oldfors, A ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

FKRP mutation; Limb girdle muscular dystrophy; Myoglobinuria

Indexed keywords

ALANINE AMINOTRANSFERASE; ALPHA DYSTROGLYCAN; ASPARTATE AMINOTRANSFERASE; CREATINE KINASE; MYOGLOBIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE SEVERITY; EXERCISE; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; INCIDENCE; LIMB GIRDLE MUSCULAR DYSTROPHY; LIMB GIRDLE MUSCULAR DYSTROPHY TYPE 2I; MALE; MUSCLE BIOPSY; MYALGIA; MYOGLOBINURIA; RECURRENT DISEASE; URINE COLOR;

ADULT; EXERCISE; HUMANS; MUSCLE, SKELETAL; MUSCULAR DYSTROPHIES, LIMB-GIRDLE; MUTATION; MYOGLOBINURIA; PHENOTYPE; RECURRENCE;

EID: 84858285195     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2011.01608.x     Document Type: Article

References (13)

1. Brockington M, Yuva Y, Prandini P et al. Mutations in the fukutin-related protein gene (FKRP) identify limb girdle muscular dystrophy 2I as a milder allelic variant of congenital muscular dystrophy MDC1C. Hum Mol Genet 2001;10:2851-9.
2. Brockington M, Blake DJ, Prandini P et al. Mutations in the fukutin-related protein gene (FKRP) cause a form of congenital muscular dystrophy with secondary laminin α2 deficiency and abnormal glycosylation of α-dystroglycan. Am J Hum Genet 2001;69:1198-209.
3. Poppe M, Cree L, Bourke J et al. The phenotype of limb-girdle muscular dystrophy type 2I. Neurology 2003;60:1246-51.
4. Boito CA, Melacini P, Vianello A et al. Clinical and molecular characterization of patients with Limb-girdle muscular dystrophy type 2I. Arch Neurol 2005;62:1894-9.
5. Guglieri M, Magri F, D'Angelo MG et al. Clinical, molecular and protein correlations in a large sample of genetically diagnosed Italian limb girdle muscular dystrophy patients. Hum Mutat 2008;29:258-66.
6. Gaul C, Descheauer M, Tempelmann C et al. Cardiac involvement in limb-girdle muscular dystrophy 2I: conventional cardiac diagnostic and cardiovascular magnetic resonance. J Neurol 2006;253:1317-22.
7. Schwartz M, Hertz JM, Sveen ML, Vissing J. LGMD2I presenting with a characteristic Duchenne or Becker muscular dystrophy phenotype. Neurology 2005;64:1635-7.
8. Stensland E, Lindahl S, Jonsrud C et al. Prevalence, mutation spectrum and phenotypic variability in Norwegian patients with Limb Girdle Muscular Dystrophy 2I. Neuromuscul Disord 2011;21:41-6.
9. Quinlivan R, Buckley J, James M et al. McArdle disease: a clinical review. J Neurol Neurosurg Psychiatry 2010;81:1182-8.
10. Anichini A, Fanin M, Vianey-Saban C et al. Genotype-phenotype correlations in a large series of patients with muscle type CPT II deficiency. Neurol Res 2011;33:24-32.
11. Doriguzzi C, Palmucci L, Mongini T, Chiadò-Piat L, Restagno G, Ferrone M. Exercise intolerance and recurrent myoglobinuria as the only expression of Xp21 Becker type muscular dystrophy. J Neurol 1993;240:269-70.
12. Sveen ML, Schwartz M, Vissing J. High prevalence and phonotype-genotype correlations of limb girdle muscular dystrophy type 2I in Denmark. Ann Neurol 2006;59:808-15.
13. Brown SC, Torelli S, Brockington M et al. Abnormalities in α-dystroglycan expression in MDC1C and LGMD2I muscular dystrophies. Am J Pathol 2004;164:727-37.